The China 3D cardiac mapping market was valued at $55.55 million in 2019, and is projected to reach $150.59 million by 2027, registering a CAGR of 12.8% from 2020 to 2027.
3D cardiac mapping is a technique that is widely accepted for identification, characterization, and localization of an arrhythmia. Cardiac mapping is a procedure in which the information from cardiac electrograms is collected and displayed. It is used to diagnose heart rhythms particularly in case of arrhythmia. This procedure is commonly done by injecting catheter into the heart chamber percutaneously to record electrograms sequentially, which is done to correlate electrograms in cardiac anatomy. New 3D cardiac mapping systems create three-dimensional model of any chamber of heart and can track exact location of the catheter. This allows movement of catheters without using X-ray. They are designed to expand the resolution and gain rapid cardiac activation maps.Advanced features offered by these mapping provideaccurate three-dimensional view of a cardiac chamber with a straightforward geometric display that has the capability to determine location and orientation of ablation catheter accurately.
Due to COVID 19 pandemic other healthcare segments have to face negligence. In addition, Coronavirus (COVID-19) was discovered in late December in Hubei province of Wuhan city in China. China is the center of this lethal disease. Furthermore, this disease predominantly affects the lungs, often leading to pneumonia and acute respiratory distress syndrome, adverse effects on the heart have also been observed.Conversely it has been observed that there is prevalence of Novel coronavirus in patients suffering with conditions like arrhythmia around 16.7 percent of patients developed arrhythmia. For this condition mainly 3D cardiac mapping is used. All these factors are anticipated to impact the china 3D cardiac mapping market as well in the future.
Furthermore, preference of 3D cardiac mapping systems has witnessed a significant growth in recent years, owing to rise in demand for minimally invasive procedures. Patients most commonly resist undergoing open surgical procedures, which leads to increase in demand for minimally invasive procedures.High level of precision along with quick recovery offered by minimally invasive surgeries ensure its adoption by hospitals and clinics at a large scale. In addition, growth in demand for minimally invasive surgeries in China contributes to the market growth of 3D cardiac mapping.
The China 3D cardiac mapping market is expected to witness an exponential growth during the forecast period, owing to benefits of using these advanced devices over conventional products and rise in healthcare expenditure. As per data published by the National Center for Cardiovascular Diseases, total number of CVD (cardiovascular diseases) patients in China was 290 million, in 2017.Moreover, geriatric population in China continues to grow at an exceptional rate and the proportion of elderly population is more prone to cardiovascular diseases. Incidences of cardiac arrhythmias in aged people are more as compared to adult population, owing to long life expectancy and life style modifications. Hence, rise in incidences of cardiac arrhythmias is expected to provide high market growth and opportunities, thereby attracting numerous market players resulting in the development of more innovative products or product line extensions.
Growth of the China 3D cardiac mapping market is majorly driven by surge in prevalence of cardiac arrhythmias, rise in preference for minimally invasive procedures, and increase in geriatric population. However, high cost of 3D cardiac mapping hinders the market growth. On the contrary, rise in preference for 3D cardiac mapping is expected to provide significant profitable opportunities for manufacturers in the China 3D cardiac mapping market.
China 3d Cardiac Mapping Market Segmentation
The China 3D cardiac mapping market is segmented on the basis of application and end user. By application, it is divided into electroanatomical mapping, basket catheter mapping, and real-time positional management (cardiac pathways) EP system. By end user, it is segmented into hospitals, clinics, and diagnostics centers
Application segment review
By application, the electroanatomical mapping segment accounted for the highest market share in 2019, and is expected to exhibit a prominent growth in the future, owing to advancements that allow operators to record intra-cardiac electrical activation in relation to anatomic location in a cardiac chamber of interest, throughout arrhythmia (irregular heart beat) mapping. Hence, the demand for electroanatomical mapping is high, owing to various benefits that it provides to patients. In addition, with electroanatomical mapping patients can get accurate, real-time visualization of cardiac anatomy. Moreover, advantages of electroanatomical mapping are anticipated to create newer opportunities for3D cardiac mapping in the future. Advanced features offered by these mapping provideaccurate three-dimensional view of a cardiac chamber with a straightforward geometric display that has the capability to determine location and orientation of ablation catheter accurately.
By Application
Electroanatomical Mapping segment holds a dominant position in 2019 and would continue to maintain the lead over the forecast period.
End User Segment Review
On the basis of end user, the hospitals segment dominated the China 3D cardiac mapping market in 2019, and is anticipated to maintain its dominance throughout the forecast period, owing to the fact that cardiac mapping is majorly used in hospitals and clinics to perform complex arrhythmias. Moreover, surge in incidences of cardiovascular diseases in China has led to considerable rise in hospital visits by patients since recent years. Preference among patients to visit hospitals for their checkup or disease diagnosis is anticipated to propel the market growth in the future.
By End User
Hospitals segment is projected as one of the most lucrative segment.
Comprehensive competitive analysis and profiles of major market players such as Abbott Laboratories, Microport Scientific Corporation, Medtronic Plc, and Acutus Medical provided in this report.
Key Benefits For Stakeholders
This report entails a detailed quantitative analysis along with the current trends of the China 3D cardiac mapping market trends from 2019 to 2027 to identify the prevailing opportunities along with strategic assessments.
An in-depth market analysis includes analysis of China is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
A comprehensive analysis of the factors that drive and restrain the growth of the market is provided.
The market forecast is studied from 2020 to 2027.
The market size and estimations are based on a comprehensive analysis of key developments in the industry.
A qualitative analysis based on innovative products facilitates strategic business planning.
The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.
China 3D cardiac mapping Market Report Highlights
| Aspects | Details |
 By TECHNOLOGY |
|
 By End User |
|
 Key Market Players | Abbott Laboratories, MicroPort Scientific Corporation, Medtronic Plc., Acutus Medical |
Analyst Review
China 3D cardiac mapping is expected to witness high adoption rate and has gained significant attention over past few years.
The China 3D cardiac mapping market has piqued the interest of hospitals, diagnostics centers, and clinics, owing to several benefits offered by this mapping system to reduce healthcare expenditure and improve patient outcomes. There have been remarkable technological advancements in 3D cardiac mapping in China such as development of novel technologies from major companies. Rise in geriatric population who are more prone to chronic heart disorders is anticipated to raise the demand for 3D cardiac mapping systems.
According to the perspectives of CXOs, big data in the health care industry is projected to increase the adoption rate of 3D cardiac mapping in China. Moreover, emergence of non-invasive 3Dcardiacmapping systems is anticipated to boost the growth of the China 3D cardiac mapping market.
The total market value of china 3D cardiac mapping market is $55.55 million in 2019.
The forcast period for china 3D cardiac mapping market is 2020 to 2027
The market value of china 3D cardiac mapping market in 2020 is $64.82 million.
The base year is 2019 in china 3D cardiac mapping market
Top companies such as, Abbott Laboratories, Microport Scientific Corporation, Medtronic Plc, and Acutus Medical held a high market position in 2019. These key players held a high market postion owing to the strong geographical foothold in china.
Electroanatomical mapping system segment is the most influencing segment owing advancements that allows operators to record intracardiac electrical activation in relation to anatomic location in a cardiac chamber of interest, throughout arrhythmia (irregular heart beat) mapping. Hence, this increases the demand for 3D cardiac mapping, which boosts the growth of the market.
The major factor that fuels the growth of the china 3D cardiac mapping market includes surge in prevalence of cardiac arrhythmias, rise in geriatric population and others. This leads to surge in demand for china 3D cardiac mapping devices which contribute to the growth of the market.
China has the highest growth rate which is growing due to increase in number of cardiac arrhythmias patients in China and benefits of using advanced 3D cardiac mapping systems CAGR of 12.6%. This is due to improvement in health awareness, development in healthcare infrastructure, and rise in number of hospitals & diagnostic centers equipped with advanced medical facilities.
3D cardiac mapping systems give three-dimensional view of a patient’s heart, which helps electrophysiologists to identify the site of origin of any irregular rhythm accurately and deliver radio-frequency catheter ablation therapy with high success rate
3D cardiac mapping procedure of heart that is used to diagnose the origins of arrhythmias.
Loading Table Of Content...
